TY - JOUR
KW - *Diabetes Mellitus/ep [Epidemiology]
KW - *Dyslipidemias/ep [Epidemiology]
KW - *Hypertension/ep [Epidemiology]
KW - *Schizophrenia/co [Complications]
KW - 0 (Antihypertensive Agents)
KW - 0 (Blood Glucose)
KW - Antihypertensive Agents/tu [Therapeutic Use]
KW - Blood Glucose
KW - Blood Pressure
KW - Clinical Trials as Topic
KW - Diabetes Mellitus/th [Therapy]
KW - Dyslipidemias/th [Therapy]
KW - Female
KW - Humans
KW - Hypertension/th [Therapy]
KW - Male
KW - Prevalence
KW - Risk Factors
AU - Henry A. Nasrallah
AU - Jonathan M. Meyer
AU - Donald C. Goff
AU - Joseph P. McEvoy
AU - Sonia M. Davis
AU - T. S. Stroup
AU - Jeffrey A. Lieberman
A1 - 
BT - Schizophr Res
C5 - General Literature
CP - 1-3
IS - 1-3
JF - Schizophr Res
PY - 2006
SN - 0920-9964
SP - 15
EP - 22
EP - 
T1 - Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline
T2 - Schizophr Res
TI - Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline
U1 - General Literature
VL - 86
VO - 0920-9964
Y1 - 2006
ER -